Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
36,961
Total Claims
$1.7M
Drug Cost
930
Beneficiaries
$1,868
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
-90%
Opioid rate vs peers
0.2% vs 2.5% avg
+66%
Cost per patient vs peers
$1,868 vs $1,128 avg
+32%
Brand preference vs peers
11.1% vs 8.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.2%
Opioid Rate
89
Opioid Claims
$732
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 4,070 claims · $1.3M
Generic: 32,516 claims · $420K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 248 | $164K |
| Dapagliflozin Propanediol | 191 | $126K |
| Insulin Glargine,hum.Rec.Anlog | 185 | $114K |
| Rivaroxaban | 126 | $97K |
| Insulin Nph Human Isophane | 213 | $88K |
| Empagliflozin | 88 | $70K |
| Sitagliptin Phosphate | 54 | $45K |
| Linagliptin | 68 | $43K |
| Levothyroxine Sodium | 662 | $40K |
| Insulin Nph Hum/Reg Insulin Hm | 94 | $40K |
| Insulin Glargine,hum.Rec.Anlog | 44 | $27K |
| Candesartan Cilexetil | 341 | $26K |
| Sitagliptin Phos/Metformin Hcl | 25 | $23K |
| Insulin Lispro Protamin/Lispro | 29 | $23K |
| Budesonide/Formoterol Fumarate | 57 | $22K |
Prescribing Profile
Patient Profile
74
Avg Age
57%
Female
1.53
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data